These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34262555)

  • 21. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.
    Francis ME; Goncin U; Kroeker A; Swan C; Ralph R; Lu Y; Etzioni AL; Falzarano D; Gerdts V; Machtaler S; Kindrachuk J; Kelvin AA
    PLoS Pathog; 2021 Jul; 17(7):e1009705. PubMed ID: 34265022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review on Role of Inflammation in Coronavirus Disease.
    Lotfi A; Hajian P; Abbasi L; Gargari MK; Fard NNG; Naderi D
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1488-1505. PubMed ID: 38303532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
    Tan LY; Komarasamy TV; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():742941. PubMed ID: 34659238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
    Attiq A; Yao LJ; Afzal S; Khan MA
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.
    Zimecki M; Actor JK; Kruzel ML
    Int Immunopharmacol; 2021 Jun; 95():107571. PubMed ID: 33765614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocytes and macrophages in COVID-19: Friends and foes.
    Meidaninikjeh S; Sabouni N; Marzouni HZ; Bengar S; Khalili A; Jafari R
    Life Sci; 2021 Mar; 269():119010. PubMed ID: 33454368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.
    Henriques-Pons A; Beghini DG; Silva VDS; Iwao Horita S; da Silva FAB
    Front Immunol; 2021; 12():780900. PubMed ID: 35095855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
    Petrey AC; Qeadan F; Middleton EA; Pinchuk IV; Campbell RA; Beswick EJ
    J Leukoc Biol; 2021 Jan; 109(1):55-66. PubMed ID: 32930456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
    Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 and Sepsis.
    Koçak Tufan Z; Kayaaslan B; Mer M
    Turk J Med Sci; 2021 Dec; 51(SI-1):3301-3311. PubMed ID: 34590796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
    Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.